Simulations Plus has established strategic partnerships with three pharmaceutical companies. The goal of the collaboration is to advance modeling using artificial intelligence (AI) in the process of developing new drugs. Partnership programs focus on using AI for more efficient and accurate drug development. The specific details of the projects and the identity of the partner pharmaceutical companies were not disclosed. This collaboration represents a step forward in the integration of AI technologies into the pharmaceutical industry. The partnerships are expected to bring innovative solutions and accelerate the development of new medicines. Simulations Plus specializes in pharmaceutical and biotech modeling and simulation software and services.